As of 2026-04-04, the Intrinsic Value of Eurofins Scientific SE (ERF.PA) is 36.50 EUR. This ERF.PA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 66.90 EUR, the upside of Eurofins Scientific SE is -45.40%.
The range of the Intrinsic Value is 21.86 - 70.54 EUR
Based on its market price of 66.90 EUR and our intrinsic valuation, Eurofins Scientific SE (ERF.PA) is overvalued by 45.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 21.86 - 70.54 | 36.50 | -45.4% |
| DCF (Growth 10y) | 29.29 - 81.65 | 45.19 | -32.5% |
| DCF (EBITDA 5y) | 39.18 - 89.52 | 51.53 | -23.0% |
| DCF (EBITDA 10y) | 42.75 - 96.40 | 56.86 | -15.0% |
| Fair Value | 13.03 - 13.03 | 13.03 | -80.52% |
| P/E | 60.22 - 100.45 | 78.51 | 17.3% |
| EV/EBITDA | 62.74 - 372.38 | 150.81 | 125.4% |
| EPV | 42.96 - 63.86 | 53.41 | -20.2% |
| DDM - Stable | 17.77 - 46.82 | 32.30 | -51.7% |
| DDM - Multi | 22.49 - 45.94 | 30.18 | -54.9% |
| Market Cap (mil) | 12,186.50 |
| Beta | 0.91 |
| Outstanding shares (mil) | 182.16 |
| Enterprise Value (mil) | 15,827.50 |
| Market risk premium | 5.82% |
| Cost of Equity | 10.64% |
| Cost of Debt | 4.25% |
| WACC | 8.54% |